Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster session 19

CN22 - Patient reported experiences (PREM): Cancer care pathway in the Stockholm-Gotland region

Date

10 Sep 2022

Session

Poster session 19

Topics

COVID-19 and Cancer

Tumour Site

Presenters

Åsa Wilson

Citation

Annals of Oncology (2022) 33 (suppl_7): S812-S814. 10.1016/annonc/annonc1042

Authors

Å. Wilson1, B. Sunde2

Author affiliations

  • 1 Oncology, Visby Lasarett, 621 84 - Visby/SE
  • 2 Clintec, Karolinska Institutet - Cancer Center Karolinska (CCK), 171 76 - Stockholm/SE

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Abstract CN22

Background

Patient satisfaction is a goal that is part of the Swedish initiative for cancer care pathway (CCP). A questionnaire has been developed specifically to request patients` experiences (PREM) of care and an overall goal is that the patient perspective has a clear influence in the follow-up and evaluation of CCP. The purpose of this project is to describe patient reported experiences from CCP in the Stockholm-Gotland Region, during the period 2017 to q1 2021. It includes patients’ experiences from CCP, comparisons between groups and whether it differs before and during the COVID-19 pandemic.

Methods

An invitation letter to complete a validated PREM questionnaire consisting of 34 questions, is sent to patients 8-10 weeks after CCP has ended. The main questions consist of seven dimensions and own comments can be shared.

Results

A total of 14,141 persons responded to the questionnaire with an average response rate of 57%. Representativeness is good for patients where the investigation led to a cancer diagnosis, among the elderly and among patients who have undergone care processes for breast cancer, colon and rectal cancer, prostate cancer, bladder cancer or skin melanoma. Most of the patients are satisfied with CCP regarding overall impression, respect & treatment, continuation & coordination, information & knowledge, and availability. However, areas that can be improved are emotional support as well as participation & involvement. Where the investigation did not lead to a cancer diagnosis and during the COVID-19 pandemic has affected the relative’s situation negatively, both in terms of relatives' opportunity to participate in care and the relative's opportunity to get in touch with health care regarding their own issues or need of support.

Conclusions

Most of the patients are satisfied with CCP. Areas that might be improved are emotional support as well as participation & involvement. The COVID-19 pandemic has affected the relatives' situation negatively.

Clinical trial identification

Editorial acknowledgement

Legal entity responsible for the study

Region Stockholm-Gotland.

Funding

Has not received any funding.

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.